C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
12/2009
12/01/2009	US7625917 S-o-(phenylaminocarbonyl)phenyl-substituted, especially with a quaternary onium group; enhanced antiviral activity and better reactivity with zinc finger moieties, particularly, the zinc finger on HIV-1's NCp7 nucleocapsid protein
12/01/2009	US7625914 2(S)-Ethoxy-3-{4-[2-(3-heptyl-1-methylureido)thiazol-4-yl]phenyl}propanoic acid; dermatology, and cardiovascular diseases, immune diseases, lipid metabolism diseases; veterinary medicine
12/01/2009	US7625912 2-Phenylpyrimidinone compounds; anticarcinogenic agents can be synergistically combined with one or more active ingredients such as paclitaxel or trastuzumab; side effect reduction
12/01/2009	US7625911 Amorphous form of erlotinib hydrochloride and its solid amorphous dispersion
12/01/2009	US7625909 N-{3-[2-(2-Fluoro-4-methoxyphenyl)-ethyl]-4-oxo-3,4-dihydroquinazolin-7yl}-N-indan-2-yl-3,5-dimethylpiperazine-1-carboxamidine; melanocortin-4 receptor agonists; diabetes
12/01/2009	US7625908 Antiproliferative agent in the prevention or treatment of tumors which are sensitive to inhibition of EGF and erbB receptor tyrosine kinases;1-({4-[(3-chloro-2-fluorophenyl)amino]-7-methoxyquinazolin-6-yl}methyl)-L-prolinamide
12/01/2009	US7625899 antiproliferative, antitumor and anticarcinogenic agent; cyclin dependent kinase inhibitor
12/01/2009	CA2389412C N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them
11/2009
11/26/2009	WO2009143361A1 Amido anti-viral compounds
11/26/2009	WO2009143183A1 Pyrimidine non-classical cannabinoid compounds and related methods of use
11/26/2009	WO2009143049A1 Bicyclic heterocycle derivatives and use thereof as gpr119 modulators
11/26/2009	WO2009141292A1 Substituted heteroarylmethyl sulfonamides
11/26/2009	WO2009141291A1 Substituted heteroarylmethyl sulfonamides
11/26/2009	WO2009141167A1 Bosentan salts
11/26/2009	WO2009140863A1 Compositions comprising quinazoline derivatives, preparation methods and uses thereof
11/26/2009	WO2009050506A3 Combination 059
11/26/2009	WO2009024251A3 Use of sulfonanilide compounds as herbicide
11/26/2009	US20090291973 Novel Quinazoline Derivatives and Their Medical Use
11/26/2009	US20090291971 Heteroaryl ethers and processes for their preparation
11/26/2009	US20090291970 Substituted Aminoethers for the Treatment of Alzheimer's Disease
11/26/2009	US20090291951 Novel Cyclic Compound Having Pyrimidinylalkylthio Group
11/26/2009	US20090291950 Bicyclic heteroaryl inhibitors of pde4
11/26/2009	CA2724737A1 Pyrimidine non-classical cannabinoid compounds and related methods of use
11/26/2009	CA2724426A1 Bicyclic heterocycle derivatives and use thereof as gpr119 modulators
11/25/2009	EP2123647A1 2-(amino-substituted)-4-phenyl pyrimidines useful for treating inflammatory diseases
11/25/2009	EP2123641A1 Crystal, amorphous form and salt of methyl n-ý3-(6,7-dimethoxy- 2-methylaminoquinazolin-4-yl)phenyl¨terephthalamic acid
11/25/2009	EP2121635A2 Substituted heteroaryl pyridopyrimidone derivatives
11/25/2009	EP2121634A1 Pyrimidine-2,4-diamine derivatives and their use as jak2 kinase inhibitors
11/25/2009	EP2121633A2 Piperazine derivatives for treatment of ad and related conditions
11/25/2009	EP2121631A2 Triol form of rosuvastatin
11/25/2009	EP2121591A2 Ppar active compounds
11/25/2009	EP1242385B1 Cytokine, especially tnf-alpha, inhibitors
11/25/2009	CN101589028A Process for production of phenylalanine derivatives having quinazolinedione skeletons and intermediates for the production
11/25/2009	CN101589026A Method of treatment of glioma brain tumour
11/25/2009	CN101588716A Substance capable of inhibiting cytokinin signaling
11/25/2009	CN101585814A Aryl pyrimidine ortho-single halogen substituted compound and synthetic method thereof
11/25/2009	CN101585806A Azo comounds or their salt and process for producing the same
11/25/2009	CN101584691A Compounds effecting glucokinase
11/25/2009	CN100562518C Novel arylethene-sulfonamides compounds
11/25/2009	CN100562516C Beta-amyloid protein production/secretion inhibitors
11/25/2009	CN100562319C 2-cyanopyrrolopyrimidines and pharmaceutical uses thereof
11/24/2009	US7622474 Asulfonyl(urea, thiourea, guanidine, cyanoguanidine) compounds; cardiovascular disorders; thrombosis
11/24/2009	CA2385859C 2'-substituted 1,1'-biphenyl-2-carboxamides, processes for their preparation, their use as medicament, and pharmaceutical preparations comprising them
11/19/2009	WO2009139330A1 Optically isotropic liquid crystalline medium, and optical element
11/19/2009	WO2009138788A1 Substituted quinazolines
11/19/2009	WO2009094442A3 5-fluoro pyrimidine derivatives as fungicides
11/19/2009	US20090286819 Process for Preparing the Calcium Salt of Rosuvastatin
11/19/2009	US20090286818 Pyridine Non-Classical Cannabinoid Compounds and Related Methods of Use
11/19/2009	US20090286817 Tryptophan hydroxylase inhibitors; anticarcinogenic agents; gastrointestinal, cardiovascular, and respiratory system disorders; (S)-2-amino-3-[4-(2-amino-6-{R-1-[4-chloro-2-(3-methyl-pyrazol-1-yl)-phenyl]-2,2,2-trifluoro-ethoxy}-pyrimidin-4-yl)-phenyl]-propionic acid ethyl ester
11/19/2009	US20090286814 Hcv protease inhibitors
11/19/2009	US20090286810 Pyrimidine Non-Classical Cannabinoid Compounds and Related Methods of Use
11/19/2009	US20090286809 Preventives or remedies for alzheimer's disease, or amyloid protein fibril-formation inhibitors, which include a nitrogen-containing heteroaryl compound
11/19/2009	US20090286794 Preventives or remedies for alzheimer's disease, or amyloid protein fibril-formation inhibitors, which include a nitrogen-containing heteroaryl compound
11/19/2009	US20090286790 Organic compounds
11/19/2009	US20090286776 Hexenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications thereof
11/19/2009	US20090286261 Method for assaying compounds or agents for ability to displace potent ligands of hematopoietic prostaglandin d synthase
11/19/2009	US20090285849 Thiosemicarbazones as anti-virals and immunopotentiators
11/19/2009	US20090285783 Methods and compositions for cancer therapy using a novel adenovirus
11/19/2009	US20090285782 4,6-di- and 2,4,6-trisubstituted quinazoline derivatives useful for treating viral infections
11/19/2009	CA2723857A1 Substituted quinazolines
11/19/2009	CA2722970A1 Synthesis of dihydrothieno[3,2-d]pyrimidine diols and similar pyrimidine diols
11/18/2009	EP2119708A1 Tetrahydroquinazoline compounds and their use in preparing medicaments for treating and preventing virosis
11/18/2009	EP2118075A1 Bicyclic heterocycles, drugs containing said compounds, use thereof, and method for production thereof
11/18/2009	EP2118074A1 Compounds for the prevention and treatment of cardiovascular diseases
11/18/2009	EP2118073A2 Selective endothelin type-a antagonists
11/18/2009	EP1928842B1 4-phenyl-6-substituted-pyrimidine-2-carbonitrile derivatives
11/18/2009	EP1888538B1 (3,4-dihydro-quinazolin-2-yl)-(2-aryloxy-ethyl)-amines having an activity on the 5-ht receptor
11/18/2009	EP1873148B1 Pharmaceutical compositions containing crystalline salts of 7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]-(3R,5S)-3,5-dihydroxyhept-6-enoic acid
11/18/2009	EP1587474B1 Fluoroalkoxy-substituted 1, 3-dihydro-isoindolyl compounds and their pharmaceutical uses
11/18/2009	EP1306372B1 Heterocycle derivatives and drugs
11/18/2009	EP1280781B1 5-ht 7 receptor antagonists
11/18/2009	EP1218354B1 Quinazoline derivatives and their use as pharmaceuticals
11/18/2009	EP0892789B2 Irreversible inhibitors of tyrosine kinases
11/18/2009	CN101583611A Inhibitors of hepatitis C virus
11/18/2009	CN101583604A Synthesis of 4-amino-pyrimidines
11/18/2009	CN101583600A Acetylene derivatives as stearoyl CoA desaturase inhibitors
11/18/2009	CN101580493A Poly-substituted miazines compound, preparation method and application thereof
11/18/2009	CN100560073C N4-acylcytosine nucleosides for treatment of viral infections
11/17/2009	US7619084 Reacting an acrylonitrile, ammonia and alkyl orthoformate in an ammonia-isopropyl alcoholsolution under stirring at 145 degrees C. for 12 hours; nonteratogenicity, nontoxic; simplification; industrial scale; chemical intermediates; drugs; agricultural chemicals
11/17/2009	US7618977 Method of treating dermatitis comprising administering a chymase inhibitor
11/17/2009	US7618975 4-arylamino-quinazolines and analogs as activators of caspases and inducers of apoptosis; antiproliferative, anticarcinogenic, antimetabolic agents; tubulin and topoisomerase II inhibitors; fungicides; synergistic administration with other anticarcinogenic agents
11/17/2009	US7618963 Bicyclic heteroaromatic compounds
11/17/2009	CA2588495C The utility of uridine nucleosides in the treatment of cachexia
11/17/2009	CA2463272C Piperazine derivatives with ccr1 receptor antagonist activity
11/17/2009	CA2397450C Crystalline salts of 7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]-(3r,5s)-3,5-dihydroxyhept-6-enoic acid
11/17/2009	CA2393809C Heterocyclic dihydropyrimidines as potassium channel inhibitors
11/12/2009	WO2009137797A2 Quinazoline derivatives
11/12/2009	WO2009136995A2 Inhibitors of syk protein kinase
11/12/2009	WO2009135455A2 Method for producing gemcitabine hydrochloride and intermediate products
11/12/2009	US20090281316 Process for the preparation of substituted cyanophenoxy-pyrimidinyloxy-phenyl acrylate derivatives
11/12/2009	US20090281315 Forms of lapatinib ditosylate and processes for preparation thereof
11/12/2009	US20090281131 Diebenzofuran derivatives as inhibitors of pde-4 and pde-10
11/12/2009	US20090281128 Caspase inhibitors and uses thereof
11/12/2009	US20090281123 Novel thiazolo (4,5-d) pyrimidine compounds novel compounds
11/12/2009	US20090281072 Diaminopyrimidinecarboxamide Derivative
11/12/2009	US20090281063 Iontophoretic preparation for treatment of breast cancer and/or mastitis
11/12/2009	US20090280133 Pharmaceutical compounds as inhibitors of cell proliferation and the use thereof
11/12/2009	US20090280081 JAK/STAT pathway inhibitors and uses thereof
11/12/2009	DE102008026341A1 Katalysatoren zur Synthese von Polyurethanen Catalysts for the synthesis of polyurethanes
11/12/2009	DE102008023301A1 Neue nukleophile Cytosin-Derivate und ihre Anwendungen New nucleophilic cytosine derivatives and their applications

1 ... 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 ... 427